8QYA
J22.9-FNY, fully humanized, CDR optimized Fab Fragment based on chimeric J22.9-xi IgG against BCMA; with VH CDR2 glycosylation
Summary for 8QYA
Entry DOI | 10.2210/pdb8qya/pdb |
Related | 4zfo 8QY9 8QYB |
Descriptor | J22.9-FNY Fab antibody light chain, J22.9-FNY Fab antibody heavy chain, Tumor necrosis factor receptor superfamily member 17, ... (6 entities in total) |
Functional Keywords | fab fragment, humanized, cdr derivatized, bcma binding, immune system |
Biological source | Mus musculus More |
Total number of polymer chains | 3 |
Total formula weight | 51035.26 |
Authors | Marino, S.F.,Daumke, O. (deposition date: 2023-10-25, release date: 2024-01-17, Last modification date: 2024-09-11) |
Primary citation | Marino, S.F.,Daumke, O. Structure-based humanization of a therapeutic antibody for multiple myeloma. J.Mol.Med., 102:1151-1161, 2024 Cited by PubMed: 39052065DOI: 10.1007/s00109-024-02470-4 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.72 Å) |
Structure validation
Download full validation report